Editorial
 MONITORING CELLS OF NPPA   
 Thursday, September 18, 2014 
 Violation of the Drug Price Control Order by the pharmaceutical companies has been a serious challenge for the government ever since the National Pharmaceutical Pricing Authority was established by the Union ministry of chemicals & fertilizers in 1997. 
  Past Editorial...  
TODAY'S NEWS
16:00  [IST]Spectrum grants its rights of 3 drugs to CASI Pharma to develop and commercialise in China
15:00  [IST]Novartis data in The Lancet Oncology show LBH589 offers 4-month increase in median PFS for multiple myeloma patients
14:00  [IST]LABSCO amends distributorship agreement with Sysmex America
13:00  [IST]US FDA approves Stendra for erectile dysfunction treatment
12:00  [IST]Eli Lilly's Trulicity receives US FDA approval to treat adults with type 2 diabetes
11:00  [IST]Sigma-Aldrich enters new gene editing partnership with University of Michigan Medical School
more news >>
TOP NEWS
08:00  [IST]Rajasthan to train drug inspectors following NPPA's plan to set up price modulating cells
08:00  [IST]Panellists at Pharmexcil’s 10th annual meet propose to set up resource group for rare disease
08:00  [IST]Anthem’s invests Rs.150 cr for its new synthesis fermentation manufacturing unit
08:00  [IST]IHPA demands establishment of directorate of pharmaceutical services for the welfare of pharmacists
08:00  [IST]CURA Technologies introduce DReam Digital Radiography Systems
08:00  [IST]Health ministry to revise Schedule M-III for medical devices to make it harmonious with international standards
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA clears Soligenix's phase 3 clinical protocol of SGX301 in CTCL
17:05  [IST]GlaxoSmithKline to pay fine of £297 mn to Chinese government
17:00  [IST]Sagent Pharma launches ketorolac tromethamine injection, USP
16:00  [IST]Immune Pharma begins phase II trial in ulcerative colitis
15:00  [IST]CTI BioPharma, Servier team up to develop and commercialise Pixuvri
14:40  [IST]Dr S Manivannan, Dy DCGI, takes addl charge of sub-zone CDSCO Bengaluru
more news >>
INTERVIEW  
Gujarat FDCA: Playing crucial role in industry growth
Dr_H-G-Koshia.jpgDr H G Koshia, Gujarat FDCA commissioner
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |